Education
About Us
Working with TipRanks
Follow Us
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 138.39M | $ 157.75M | $ 205.75M | $ 12.36M | $ 9.54M |
| Gross Profit | $ 138.39M | $ 157.75M | $ 205.75M | $ 12.36M | $ -46.41M |
| Operating Income | $ -95.67M | $ -78.20M | $ 12.18M | $ -202.85M | $ -71.52M |
| EBITDA | $ -77.40M | $ -24.16M | $ 13.70M | $ -201.66M | $ -70.64M |
| Net Income | $ -80.94M | $ -29.73M | $ 9.35M | $ -203.67M | $ -72.15M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 237.03M | $ 292.00M | $ 391.88M | $ 370.49M | $ 462.89M |
| Total Assets | $ 344.07M | $ 429.40M | $ 450.39M | $ 392.81M | $ 476.46M |
| Total Debt | $ 28.55M | $ 30.22M | $ 94.75M | $ 69.15M | $ 20.75M |
| Net Debt | $ -208.48M | $ -261.79M | $ -297.13M | $ -301.35M | $ -442.14M |
| Total Liabilities | $ 103.09M | $ 150.89M | $ 180.07M | $ 164.60M | $ 79.90M |
| Stockholders' Equity | $ 240.98M | $ 278.51M | $ 270.31M | $ 228.21M | $ 396.55M |
| Cash Flow | |||||
| Free Cash Flow | $ -60.40M | $ -21.00M | $ 24.27M | $ -138.45M | $ -44.60M |
| Operating Cash Flow | $ -59.75M | $ -18.10M | $ 31.99M | $ -135.04M | $ -42.86M |
| Investing Cash Flow | $ -648.00K | $ -2.90M | $ -7.73M | $ -3.41M | $ -1.74M |
| Financing Cash Flow | $ 5.42M | $ -24.09M | $ -2.86M | $ 48.02M | $ 436.14M |